Revolution Medicines, Inc. Common Stock (RVMD) is a publicly traded Healthcare sector company. As of July 5, 2026, RVMD trades at $189.24 with a market cap of $40.23B and a P/E ratio of -31.80. RVMD moved +0.79% today. Year to date, RVMD is +137.53%; over the trailing twelve months it is +408.85%. Its 52-week range spans $29.17 to $193.10. Analyst consensus is strong buy with an average price target of $185.11. Rallies surfaces RVMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for RVMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $189.24 |
| Market Cap | $40.23B |
| P/E Ratio | -31.80 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $193.10 |
| 52-Week Low | $29.17 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-1.13B |
| Gross Margin | 0.00% |
21 analysts cover RVMD: 0 strong buy, 20 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $185.11.